Katie Bullock
West Derby Street
Liverpool, ENG, United Kingdom
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for hereditary pancreatic diseases (EUROPAC-PLUS).
Journal: Neoplasia (New York, N.Y.)
Published: April 26, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.
Journal: The Journal of antimicrobial chemotherapy
Published: November 19, 2025
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.
Journal: Clinical pharmacology and therapeutics
Published: October 08, 2025
Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways.
Journal: Scientific reports
Published: January 09, 2023
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
Journal: Nature communications
Published: September 26, 2022
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Journal: The Lancet. Infectious diseases
Published: July 14, 2022
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 01, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
Journal: The Journal of antimicrobial chemotherapy
Published: June 15, 2021
Single-Nucleotide Polymorphism to Associate Cancer Risk.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 16, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026